Skip to main content
. 2014 Apr 29;12:132. doi: 10.1186/1477-7819-12-132

Table 1.

ECM1 expression, LMVD, and clinicopathological characteristics

Clinicopathological parameters N  
ECM1 expression
 
LMVD
 
- + P (LMV per × 200 field) P
Gender
 
 
 
0.618
 
0.627
Male
47
13
34
 
7.76 ± 1.21
 
Female
30
10
20
 
7.83 ± 1.23
 
Age (years)
 
 
 
0.628
 
0.553
<60
37
10
27
 
7.25 ± 1.17
 
≥60
40
13
27
 
8.34 ± 1.33
 
Differentiation degree
 
 
 
0.489
 
0.253
Low
36
11
25
 
9.25 ± 1.37
 
Moderate
23
5
18
 
5.75 ± 1.22
 
Well
18
7
11
 
7.94 ± 2.01
 
Depth of invasion
 
 
 
<0.0001***
 
0.721
T1-T2
23
18
5
 
8.77 ± 1.97
 
T3-T4
54
5
49
 
7.53 ± 0.99
 
Lymph node metastasis
 
 
 
0.521
 
0.110
0
34
9
25
 
6.74 ± 1.29
 
1-2
18
9
11
 
7.00 ± 2.46
 
3-6
10
3
7
 
11.00 ± 2.74
 
≥7
15
4
11
 
9.57 ± 1.47
 
TNM stage
 
 
 
0.0014**
 
0.241
0-I
21
12
9
 
8.50 ± 2.12
 
II-III 27 11 45   8.67 ± 1.18  

‘+’, ‘++’, and ‘+++’ for ECM1 IHC staining are grouped together as ‘+’.

T1: lamina propria and submucosa; T2: muscularis propria and subserosa; T3: exposure to serosa; T4: invasion into serosa.

**P <0.01.

***P <0.001.

P <0.05 is considered statistically significant.